Life Sciences

Pharmaceutical companies agree to reveal funding

Pharma Compliance Alert, April 16, 2008

Senator Charles Grassley (R-IA) will get the grant information he wants from some of the biggest pharmaceutical and medical device manufacturers, but Schering-Plough will not be among them, according to an Associated Press article.

Eli Lilly already discloses grant funding on its Web site, according to the article. Grassley recently asked 15 other companies if they planned to follow Lilly’s lead and if not, why not.

Two device manufacturers, Zimmer, Inc., and Stryker Orthopedics Inc., said that they already disclose their grant funding and 12 companies told Grassley that they have plans or are currently working on plans to do so. Each company will detail its plans on its own Web site. Schering-Plough was the only company that said it had no plans to publish grant information.
 
Pharmaceutical and medical device companies could be forced to disclose more than just their grant funding. In September 2007, Grassley introduced the Physician Payment Sunshine Act of 2007. If passed, the act would require pharmaceutical and device companies to disclose any payment to a physician of more than $25. A companion bill was introduced in the House of Representatives in March.

Comments

0 comments on “Pharmaceutical companies agree to reveal funding

 

Most Popular

Related Articles